GlassScriptPhysician profile
Matthew Mcewan
NPI 1699114025
$1,391.96
in general payments reported to CMS, 2019-2025
10 companies · $78.10 in 2025
The $78.10 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $375 · 2020: $181 · 2021: $26.26 · 2023: $441 · 2024: $291 · 2025: $78.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $810.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $810.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $503.69 | 2019-2023 | Wavewriter Alpha Prime 16 |
| Medtronic, INC. | $256.84 | 2023-2025 | Intellis Adaptivestim, Inceptiv |
| Nevro Corp. | $231.68 | 2023-2024 | Senza |
| Abbott Laboratories | $165.25 | 2019-2021 | |
| Horizon Therapeutics Plc | $74.96 | 2019-2020 | |
| Acera Surgical, INC. | $51.89 | 2024 | Restrata Wound Matrix |
| Ucb, INC. | $30.74 | 2020-2025 | Bimzelx |
| Axonics, INC. | $27.77 | 2023 | Axonics |
| Globus Medical, INC. | $25.33 | 2025 | Senza |
| Collegium Pharmaceutical, INC. | $23.81 | 2023 | Xtampza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Mcewan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.